The Animals Models Core represents an expanded version of the former Toxicology Core. Previous work of the Core focused on animal studies to assess toxicity of vectors in support of clinical trials and basic toxicologic research in nonhuman primates. We found that the majority of the activities of this Core were directed at addressing basic research questions. We therefore have broadened the scope of the core to support the preclinical evaluation of molecular therapies in a variety of animal models and have changed the name of the core to reflect its new mission. The foundation of the Animal Models Core is the Animal Services Unit (ASU) which provides comprehensive support in a number of animal models with a focus on mice, rats, rabbits, guinea pigs and nonhuman primates. The ASU operates a rodent facility with approximately 4000 cages and a nonhuman primate facility whose census averages 50 to 60 rhesus and cynomolgus macaques. The ASU staff provides technical, husbandry, facility, clinical and enrichment support. The Nonhuman Primate Research Program works directly with faculty to design, conduct and perform experiments in nonhuman primates. This application requests resources to support technical services for rodent, rabbit, canine and feline experiments as well as partial support for pilot experiments in nonhuman primates.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Gurda, Brittney L; De Guilhem De Lataillade, Adrien; Bell, Peter et al. (2016) Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII. Mol Ther 24:206-16
Ortved, Kyla; Wagner, Bettina; Calcedo, Roberto et al. (2015) Humoral and cell-mediated immune response, and growth factor synthesis after direct intraarticular injection of rAAV2-IGF-I and rAAV5-IGF-I in the equine middle carpal joint. Hum Gene Ther 26:161-71
Bissig-Choisat, Beatrice; Wang, Lili; Legras, Xavier et al. (2015) Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nat Commun 6:7339
Wang, Lili; Bell, Peter; Somanathan, Suryanarayan et al. (2015) Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids. Mol Ther 23:1877-87
Calcedo, Roberto; Franco, Judith; Qin, Qiuyue et al. (2015) Preexisting Neutralizing Antibodies to Adeno-Associated Virus Capsids in Large Animals Other Than Monkeys May Confound In Vivo Gene Therapy Studies. Hum Gene Ther Methods 26:103-5
Baek, Jeong-In; Choi, Soo Young; Chacon-Heszele, Maria F et al. (2014) Expression of Drosophila forkhead transcription factors during kidney development. Biochem Biophys Res Commun 446:15-7
O'Neill, S M; Hinkle, C; Chen, S-J et al. (2014) Targeting adipose tissue via systemic gene therapy. Gene Ther 21:653-61
Huang, Liwei; Xiao, An; Wecker, Andrea et al. (2014) A possible zebrafish model of polycystic kidney disease: knockdown of wnt5a causes cysts in zebrafish kidneys. J Vis Exp :
Huang, Liwei; Xiao, An; Choi, Soo Young et al. (2014) Wnt5a is necessary for normal kidney development in zebrafish and mice. Nephron Exp Nephrol 128:80-8
Adam, Virginie S; Crosariol, Marco; Kumar, Sachin et al. (2014) Adeno-associated virus 9-mediated airway expression of antibody protects old and immunodeficient mice against influenza virus. Clin Vaccine Immunol 21:1528-33

Showing the most recent 10 out of 222 publications